Market Movers Alert: PayPal (PYPL) Soars 16% on Massive Buyout Offer While ASML Posts Strong Gains

Key Highlights

Table of Contents

PayPal stock surged more than 16% following news of a combined acquisition proposal from Stripe and Advent International worth over $53 billion
ASML shares advanced after the company increased its full-year revenue outlook, driven by robust artificial intelligence-related demand
BlackRock gained 4.4% following better-than-anticipated second-quarter results and record assets under management
Aehr Test Systems skyrocketed 30% on impressive earnings results featuring 33% annual revenue expansion
Pentair shares collapsed 16% after slashing financial projections and revealing its CFO’s exit

Wednesday morning brought mixed trading signals as June’s cooler inflation figures helped calm concerns about imminent interest rate increases by the Federal Reserve. However, escalating geopolitical uncertainty in the Middle East, stemming from President Trump’s commitment to sustained military operations until Iran reaches an agreement, tempered overall market enthusiasm.

PayPal dominated headlines as the session’s standout performer. Industry sources revealed that Stripe and Advent International submitted a collaborative acquisition proposal for PayPal at $60.50 per share. The offer assigns a valuation exceeding $53 billion to the digital payments giant, representing a substantial 28% premium over its previous closing price. Sources indicate the transaction has secured approximately $50 billion in financing commitments, with equal ownership stakes planned for both acquiring parties. Neither PayPal nor Stripe provided immediate commentary on the reports.

PayPal Holdings, Inc., PYPL

Aehr Test Systems experienced a remarkable 30% surge following stellar fourth-quarter performance. The semiconductor testing company delivered 33% year-over-year revenue expansion and projected fiscal 2027 revenues between $130 million and $150 million, significantly exceeding the Street’s $85.1 million estimate. Additionally, the firm secured over $8 million in fresh silicon carbide orders, including repeat business from its largest client and a qualification purchase from a major global automotive manufacturer.

Semiconductor Sector and Corporate Results

ASML advanced 3.7% after the Netherlands-based semiconductor equipment manufacturer upgraded its annual sales forecast for the second time. The company announced plans to scale up manufacturing capacity to accommodate surging demand fueled by the artificial intelligence revolution.

Intel shares climbed 3.2% while Marvell Technology added 0.7% as semiconductor stocks attracted investor interest. Micron Technology declined 1.5%. IBM edged 0.8% higher, recovering partially from Tuesday’s 7% decline triggered by underwhelming preliminary figures. Technology and software names including Accenture, Adobe, ServiceNow, and Workday also posted gains.

BlackRock jumped 4.4% after the asset management powerhouse reported second-quarter earnings and assets under management that surpassed Wall Street forecasts. Morgan Stanley was scheduled to unveil its quarterly results before the market opened.

Wednesday’s Underperformers

Pentair plummeted 16% after dramatically reducing its second-quarter and full-year financial guidance. The industrial equipment manufacturer revised its full-year adjusted earnings per share projection to a range of $4.60 to $4.80, down considerably from its previous forecast of $5.30 to $5.40. Management attributed the revision to severe inventory challenges within its Pool division, anticipating approximately $250 million in reduced Pool segment revenue for the year. Compounding concerns, the company’s chief financial officer stepped down.

Wabash tumbled 14% following the announcement of a $100 million convertible debt offering. Management stated the funds would be allocated toward retiring outstanding obligations.

Johnson & Johnson declined 1.2% despite upgrading its annual forecast. Market participants appeared concerned about disappointing sales performance for Stelara, the company’s inflammatory bowel disease medication.

Lionsgate Studios climbed 4% amid reports the entertainment company is evaluating strategic alternatives and has attracted acquisition interest from France’s Bolloré Group.

✨ Limited Time Offer